NPSYX
NICHOLAS PARTNERS SMALL CAP GROWTH FUND
ADVISORS' INNER CIRCLE III
Expense ratio1
1.24%
Net assets2
$149.33M
Holdings2
95
Category
US Equity
Return

Investment objective & strategy

As of Feb. 2, 2026 · prospectus

Objective. The Nicholas Partners Small Cap Growth Fund (the Fund) seeks long-term capital appreciation.

Strategy. Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in securities of small-capitalization companies. This investment policy may be changed by the Fund upon 60 days prior written notice to shareholders. The Fund considers small-capitalization companies to be those with market capitalizations within the range of the market capitalizations of companies in the Russell 2000 Growth Index at the time of purchase. While the market capitalization range of the Russell 2000 Growth Index changes throughout the year, as of September 30, 2025, the market capitalization range of the index was between approximately $9 million and $25.2 billion. The Fund primarily invests in common stocks, including initial public offerings (IPOs), but … Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in securities of small-capitalization companies. This investment policy may be changed by the Fund upon 60 days prior written notice to shareholders. The Fund considers small-capitalization companies to be those with market capitalizations within the range of the market capitalizations of companies in the Russell 2000 Growth Index at the time of purchase. While the market capitalization range of the Russell 2000 Growth Index changes throughout the year, as of September 30, 2025, the market capitalization range of the index was between approximately $9 million and $25.2 billion. The Fund primarily invests in common stocks, including initial public offerings (IPOs), but may also invest in convertible securities, real estate investment trusts (REITs), exchange-traded funds (ETFs) and American Depositary Receipts (ADRs), which are certificates typically issued by a bank or trust company that represent ownership interests in securities of non-U.S., including emerging market, companies. The Fund may, from time to time, focus its investments in one or more sectors. In selecting investments to buy for the Fund, the Adviser uses a disciplined investment process that combines quantitative research tools with traditional fundamental research to seek to identify, and make timely investments in, dynamically growing companies (i.e. companies that are undergoing positive changes and have sustainable business fundamentals that enable the companies to finance their growth and manage such changes advantageously, and are poised to exceed market expectations). Such companies typically have the following characteristics: revenue and/or earnings acceleration, upward earnings revisions, a well-executed business plan, favorable competitive positioning, increasing market share, and a proven management team. The Adviser may sell a security for a variety of reasons, including if there is a change in the companys fundamentals, there is an unexplainable deterioration in the securitys trading market, the market capitalization of the company exceeds twice the market capitalization of the company in the Russell 2000 Growth Index with the largest market capitalization, or the Adviser identifies a more attractive investment opportunity. Due to its investment strategy, the Fund may buy and sell securities frequently. This may result in higher transaction costs and more capital gains tax liabilities than a fund with a buy and hold strategy.

Top holdings

As of March 31, 2026 · N-PORT
SecurityTickerValue% of fund
BWX TECHNOLOGIES INC $7.01M 4.69%
REVOLUTION MEDICINES INC $4.45M 2.98%
MODINE MFG CO $4.21M 2.82%
INSMED INC $3.84M 2.57%
KRATOS DEFENSE and SEC SOLTN INC $3.70M 2.48%
STERLING INFRASTRUCTURE INC $3.68M 2.46%
PAR PACIFIC HOLDINGS INC $3.44M 2.31%
Empresa Brasileira de Aeronautica S.A. (ADR) EMBJ $3.42M 2.29%
FTAI AVIATION LT $3.24M 2.17%
BRIDGEBIO PHARMA INC $3.21M 2.15%
View all holdings →

Allocation by sector

As of March 31, 2026 · N-PORT
View portfolio breakdown →

Portfolio moves

Dec 31, 2025 → Mar 31, 2026
Opened
28
Exited
18
Increased
13
Decreased
26
Unchanged
28

How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.

View portfolio moves →

Similar funds

Funds whose portfolios most overlap this one, by weight
FundOverlapNet exp.
Developing Growth Portfolio 26% 1.04%
LORD ABBETT DEVELOPING GROWTH FUND INC · LAGWX, LADCX, LADPX, LADYX, LADFX, LADQX, LADRX, LADSX, LADTX, LADVX, LOGWX 26% 0.60%
Driehaus Small Cap Growth Fund · DVSMX, DNSMX 25% 0.70%
View all similar funds →

Advisers

As of September 30, 2025 · N-CEN
FirmRole
Nicholas Investment Partners, L.P. Adviser

Footnotes

  1. Expense ratio as of February 2, 2026, from the fund's prospectus.
  2. Net assets and holdings count as of March 31, 2026, from the fund's N-PORT filing.

Machine-readable: JSON · Markdown. Programmatic access via the agent surface.